XML 31 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Non-current assets - intangibles
 12 Months Ended
Jun. 30, 2020
Text block [abstract]  
Non-current assets - intangibles
Note 12.
Non-current
assets - intangibles
 
 
  
Consolidated
 
 
  
2020
 
  
2019
 
 
  
A$’000
 
  
A$’000
 
  
Patents and intellectual property - at cost
  
 
2,851
 
  
 
2,851
 
Less: Accumulated amortisation
  
 
(2,851
) 
  
 
(2,851
) 
  
 
 
   
 
 
 
  
 
—  
 
  
 
—  
 
  
 
 
   
 
 
 
Licensing agreement - at acquired fair value
  
 
16,408
 
  
 
16,408
 
Less: Accumulated amortisation
  
 
(3,997
) 
  
 
(2,914
) 
  
 
 
   
 
 
 
  
 
12,410
 
  
 
13,494
 
  
 
12,410
 
  
 
13,494
 
  
 
 
   
 
 
 
Reconciliations
Reconciliations of the written down values at the beginning and end of the current and previous financial year are set out below:
 
 
  
Paxalisib licensing
agreement
A$’000
 
  
Total
A$’000
 
Balance at 1 July 2018
  
 
14,579
 
  
 
14,579
 
Additions
  
  
Disposals
  
  
Amortisation expense
  
 
(1,084
) 
  
 
(1,084
) 
  
 
 
   
 
 
 
Balance at 30 June 2019
  
 
13,494
 
  
 
13,494
 
  
 
 
   
 
 
 
Amortisation expense
  
 
(1,084
) 
  
 
(1,084
) 
  
 
 
   
 
 
 
Balance at 30 June 2020
  
 
12,410
 
  
 
12,410